MELISSA BAILEY: Open Payments
NPI 1124347455 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 28 payments from 13 companies in 2025. Trend: 2023 $170 · 2024 $1,154 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $84 |
| Lilly USA, LLC | 4 | $61 |
| Astellas Pharma US Inc | 2 | $54 |
| ABBVIE INC. | 3 | $51 |
| Phathom Pharmaceuticals, Inc. | 5 | $39 |
| PFIZER INC. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Novo Nordisk Inc | 1 | $21 |
| SI-BONE, INC. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: FREESTYLE LIBRE, MOUNJARO, Veozah, VOQUEZNA, REXULTI, TRINTELLIX, UBRELVY, Ozempic.
Industry payments across TX — which companies pay providers there.
